Skip to content

Glyco-Trol Human Glycosylated Hom. Cont.

by Clin Tech Diagnostics Corp.

510(k) K802432

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK802432 Date1 Dec 1980ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LCP
Device Class
Class II
Regulation
21 CFR Part 864.7470
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Glyco-Trol Human Glycosylated Hemoglobin Control is an assay control designed for the quantitative measurement of glycosylated hemoglobin (HbA1c) levels in blood samples. It serves as a reference standard to ensure the accuracy and reliability of hemoglobin testing, particularly in clinical hematology settings where monitoring diabetes management is critical. This control helps validate the performance of diagnostic assays by providing a known concentration of glycosylated hemoglobin for comparison.

Supplied as a ready-to-use control, the Glyco-Trol is intended for in vitro diagnostic use in laboratory settings. It is classified as a Class II device under FDA regulations (21 CFR 864.7470) and holds an FDA 510(k) clearance (K802432) with a traditional review pathway. The product is not specified as single-use or reusable, nor is it indicated for MRI compatibility. Storage conditions and sterility are not detailed in the provided data, but it is regulated under the product code LCP for assay controls in hematology. No additional regulatory markings beyond the 510(k) clearance are mentioned.

Other devices from Clin Tech Diagnostics Corp.

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Glyco-Trol Human Glycosylated Hemoglobin Control used for?

    The Glyco-Trol Human Glycosylated Hemoglobin Control is designed for quantitative measurement of glycosylated hemoglobin (HbA1c) levels in blood samples. It serves as a reference standard to validate the accuracy and reliability of HbA1c assays, which are critical for monitoring diabetes management in clinical hematology settings. By providing a known concentration of glycosylated hemoglobin, it helps ensure that diagnostic tests produce consistent and trustworthy results.

  • How is the Glyco-Trol Human Glycosylated Hemoglobin Control supplied?

    The Glyco-Trol is supplied as a ready-to-use control, meaning it is pre-prepared and does not require additional preparation steps before use in laboratory settings. This makes it convenient for immediate integration into HbA1c testing workflows, ensuring quick validation of assay performance.

  • Is the Glyco-Trol Human Glycosylated Hemoglobin Control sterile?

    The provided data does not explicitly state whether the Glyco-Trol is sterile. However, as it is intended for in vitro diagnostic use in laboratory settings, it is reasonable to assume it would be manufactured and packaged under conditions that maintain sterility. For precise handling instructions, refer to the manufacturer’s labeling or documentation.

  • Can the Glyco-Trol Human Glycosylated Hemoglobin Control be reused?

    The data does not specify whether the Glyco-Trol is single-use or reusable. Typically, assay controls like this are designed for single-use to ensure accuracy and prevent contamination. It is recommended to check the manufacturer’s instructions or packaging for clarification on usage guidelines.

  • What regulatory pathway does the Glyco-Trol Human Glycosylated Hemoglobin Control follow?

    The Glyco-Trol Human Glycosylated Hemoglobin Control holds an FDA 510(k) clearance (K802432) and is classified as a Class II device under FDA regulations (21 CFR 864.7470). It was granted clearance through a traditional review pathway by the FDA’s Hematology Advisory Committee (HE). This classification and clearance indicate that it meets regulatory standards for use as an assay control in hematology.